Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Insulin resistance: the shape of things to come.

Literature DB >> 7914619

Insulin resistance: the shape of things to come.

B Williams¹.

Abstract

Entities: Gene

Mesh：

Year: 1994 PMID： 7914619 DOI： 10.1016/s0140-6736(94)91904-6

Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321

Keyword Cloud
Cited

× No keyword cloud information.

17 in total

1. Central obesity, insulin resistance, syndrome X, lipoprotein(a), and cardiovascular risk in Indians, Malays, and Chinese in Singapore.

Authors: K Hughes; T C Aw; P Kuperan; M Choo
Journal: J Epidemiol Community Health Date: 1997-08 Impact factor: 3.710

2. Is metabolic syndrome a discrete entity in the general population? Evidence from the Caerphilly and Speedwell population studies.

Authors: J W Yarnell; C C Patterson; D Bainton; P M Sweetnam
Journal: Heart Date: 1998-03 Impact factor: 5.994

3. Strategies for reduction in the prevalence of NIDDM; the case for a population-based approach to the development of policies to deal with environmental factors in its aetiology.

Authors: B J Boucher
Journal: Diabetologia Date: 1995-09 Impact factor: 10.122

4. Xylitol prevents NEFA-induced insulin resistance in rats.

Authors: P Kishore; S Kehlenbrink; M Hu; K Zhang; R Gutierrez-Juarez; S Koppaka; M R El-Maghrabi; M Hawkins
Journal: Diabetologia Date: 2012-03-30 Impact factor: 10.122

5. Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1.

Authors: H Abe; N Yamada; K Kamata; T Kuwaki; M Shimada; J Osuga; F Shionoiri; N Yahagi; T Kadowaki; H Tamemoto; S Ishibashi; Y Yazaki; M Makuuchi
Journal: J Clin Invest Date: 1998-04-15 Impact factor: 14.808

Insulin resistance: the shape of things to come.

1. Central obesity, insulin resistance, syndrome X, lipoprotein(a), and cardiovascular risk in Indians, Malays, and Chinese in Singapore.

2. Is metabolic syndrome a discrete entity in the general population? Evidence from the Caerphilly and Speedwell population studies.

3. Strategies for reduction in the prevalence of NIDDM; the case for a population-based approach to the development of policies to deal with environmental factors in its aetiology.

4. Xylitol prevents NEFA-induced insulin resistance in rats.

5. Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1.

Review 6. Cardiometabolic syndrome: pathophysiology and treatment.

7. Arterial hypertension in diabetes mellitus: from theory to clinical practice.

Review 8. Diabetes, hypertension, and cardiovascular derangements: pathophysiology and management.

Review 9. Drug administration in patients with diabetes mellitus. Safety considerations.

10. Inhibition of glucose uptake by 5-hydroxyindoleacetic acid in the isolated rat soleus muscle.